Cargando…

Endometriosis: An Inflammatory Disease That Requires New Therapeutic Options

Detalles Bibliográficos
Autores principales:	Donnez, Jacques, Cacciottola, Luciana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836207/ https://www.ncbi.nlm.nih.gov/pubmed/35163463 http://dx.doi.org/10.3390/ijms23031518

Ejemplares similares

Can Endometriosis-Related Oxidative Stress Pave the Way for New Treatment Targets?
por: Cacciottola, Luciana, et al.
Publicado: (2021)

Profile of Linzagolix in the Management of Endometriosis, Including Design, Development and Potential Place in Therapy: A Narrative Review
por: Donnez, Jacques, et al.
Publicado: (2023)

Conservative Management of Uterine Fibroid-Related Heavy Menstrual Bleeding and Infertility: Time for a Deeper Mechanistic Understanding and an Individualized Approach
por: Dolmans, Marie-Madeleine, et al.
Publicado: (2021)

Emerging Drug Targets for Endometriosis
por: Dolmans, Marie-Madeleine, et al.
Publicado: (2022)

GnRH Antagonists with or without Add-Back Therapy: A New Alternative in the Management of Endometriosis?
por: Donnez, Jacques, et al.
Publicado: (2021)

Use of mesenchymal stem cells to enhance or restore fertility potential: a systematic review of available experimental strategies
por: Cacciottola, L, et al.
Publicado: (2023)

Long-Term Advantages of Ovarian Reserve Maintenance and Follicle Development Using Adipose Tissue-Derived Stem Cells in Ovarian Tissue Transplantation
por: Cacciottola, Luciana, et al.
Publicado: (2020)

Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review
por: Donnez, Jacques, et al.
Publicado: (2021)

Nandrolone decanoate: new therapeutic option for telomeropathies?
por: Frieri, Camilla
Publicado: (2023)

Conservative Management of Rectovaginal Deep Endometriosis: Shaving Should Be Considered as the Primary Surgical Approach in a High Majority of Cases
por: Donnez, Olivier
Publicado: (2021)

ENDO_STAGE Magnetic Resonance Imaging: Classification to Screen Endometriosis
por: Bazot, Marc, et al.
Publicado: (2022)

Endometriosis: A Disease with Few Direct Treatment Options
por: França, Patricia Ribeiro de Carvalho, et al.
Publicado: (2022)

Emerging therapeutic options in inflammatory bowel disease
por: Yamamoto-Furusho, Jesus K, et al.
Publicado: (2021)

Myocardial Diseases: Current Views on Etiopathogenesis, Diagnostic Modalities, and Therapeutic Options
por: Palecek, Tomas, et al.
Publicado: (2016)

Myopia: Risk Factors, Disease Mechanisms, Diagnostic Modalities, and Therapeutic Options
por: Mrugacz, Malgorzata, et al.
Publicado: (2018)

Mesenchymal Stromal Cells: From Therapeutic Option to Therapeutic Target
por: Stefani, Francesca Romana, et al.
Publicado: (2023)

It’s Got Too Greedy. New Therapeutic Options for Metabolic[ally] Addicted NSCLC?
por: Caiola, Elisa, et al.
Publicado: (2020)

The Use of Epigenetic Biomarkers as Diagnostic and Therapeutic Options
por: Zhang, Le, et al.
Publicado: (2022)

Hemorrhagic stroke—Pathomechanisms of injury and therapeutic options
por: Chaudhary, Neeraj, et al.
Publicado: (2019)

Leprosy stigma & the relevance of emergent therapeutic options
por: Sardana, Kabir, et al.
Publicado: (2020)

Myopia: Risk Factors, Disease Mechanisms, Diagnostic Modalities, and Therapeutic Options 2019
por: Mrugacz, Magorzata, et al.
Publicado: (2020)

Toward a New Era in the Management of Hepatocellular Carcinoma: Novel Perspectives on Therapeutic Options and Biomarkers
por: Gabbia, Daniela, et al.
Publicado: (2023)

Reconsidering evidence-based management of endometriosis
por: Koninckx, P.R., et al.
Publicado: (2022)

Leveraging MYC as a therapeutic treatment option for TNBC
por: Carey, Jason P.W., et al.
Publicado: (2018)

Udenafil as a Therapeutic Option for Pulmonary Arterial Hypertension
por: Kim, Hyung Yoon, et al.
Publicado: (2019)

Sinonasal Cancer: Improving Classification, Stratification and Therapeutic Options
por: Hermsen, Mario A., et al.
Publicado: (2023)

Current and Emerging Treatment Options in Sinus and Nasal Diseases: Surgical Challenges and Therapeutic Perspectives
por: Zhao, Xiao-Ying, et al.
Publicado: (2023)

Metformin as a Potential Treatment Option for Endometriosis
por: Kimber-Trojnar, Żaneta, et al.
Publicado: (2022)

Inflammatory Markers in Dysmenorrhea and Therapeutic Options
por: Barcikowska, Zofia, et al.
Publicado: (2020)

New treatment options for inflammatory bowel diseases
por: Verstockt, Bram, et al.
Publicado: (2018)

Editorial: New Therapeutic Options for Rare Diseases
por: Meyer, Sascha, et al.
Publicado: (2022)

Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options
por: Hrncir, Tomas
Publicado: (2022)

Present and Prospective Diagnostic and Therapeutic Options for Repeated IVF Failures
por: Sadeghi, Mohammad Reza
Publicado: (2012)

Antiangiogenic Effect of Dopamine and Dopaminergic Agonists as an Adjuvant Therapeutic Option in the Treatment of Cancer, Endometriosis, and Osteoarthritis
por: Mendoza-Torreblanca, Julieta Griselda, et al.
Publicado: (2023)

Lenvatinib in elderly hepatocellular carcinoma patients, a new therapeutic option in first line
por: Roth, Gael S., et al.
Publicado: (2020)

DNA therapeutics: a feasible option for treatment of inflammatory diseases?
por: Wagner, E
Publicado: (2001)

Uterine Adenomyosis: From Disease Pathogenesis to a New Medical Approach Using GnRH Antagonists
por: Donnez, Jacques, et al.
Publicado: (2021)

Diagnosis and Treatment of Endometriosis and Endometriosis-Associated Infertility: Novel Approaches to an Old Problem
por: Laganà, Antonio Simone, et al.
Publicado: (2022)

The potential of glioma-associated oncogene homolog 1 (GLI1) as a therapeutic target in endometriosis
por: Nirgianakis, Konstantinos, et al.
Publicado: (2020)

New data: new options for front-line therapy in NSCLC?
por: Reinmuth, Niels
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5tl4buksn4ei7snr0jej26uav2